Lifeblood receives post-donation information with relevance to recipient safety including:
- The diagnosis of a potential transfusion-transmissible infection (TTI) in a donor via internal or external testing
- A clinical history suggestive of a potential TTI in a donor
- A donor reporting a previously undisclosed risk factor for a TTI that occurred prior to donation
- A donor reporting a previously undisclosed teratogenic medication or vaccination that was administered prior to a donation.
When fresh blood components that carry a significantly increased risk of harm to a recipient have already been transfused, Lifeblood has a duty of care to notify transfusing clinicians. This document provides recommendations and rationale for clinicians to decide under what circumstances it would be appropriate to notify the transfused recipients and what actions, if any, to perform for their patients.
To assist clinicians in evaluating whether recipient notification of potential transmission of infectious disease is required, a recommendation for the notification of recipients of a recalled blood donation is available.